No Cancer Cure Due To Racial Inequity

 An effective and more affordable treatment for lung cancer may not gain approval after the Food and Drug Administration (FDA) complained about the lack of black people in its clinical trial, with a top FDA cancer official repeatedly noting in a meeting that it is Black History Month. https://www.dailywire.com/news/fda-slows-approval-of-affordable-cancer-drug-in-the-name-of-racial-equity